1726 related articles for article (PubMed ID: 23303913)
1. Pathophysiology of human visceral obesity: an update.
Tchernof A; Després JP
Physiol Rev; 2013 Jan; 93(1):359-404. PubMed ID: 23303913
[TBL] [Abstract][Full Text] [Related]
2. The regulation of adipose tissue distribution in humans.
Björntorp P
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):291-302. PubMed ID: 8680455
[TBL] [Abstract][Full Text] [Related]
3. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Maeda A; Tamura K; Wakui H; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Matsuda M; Yamashita A; Miyazaki N; Yatsu K; Hirawa N; Toya Y; Umemura S
J Am Heart Assoc; 2013 Jul; 2(4):e000312. PubMed ID: 23902639
[TBL] [Abstract][Full Text] [Related]
5. A Common Variant of NGEF Is Associated with Abdominal Visceral Fat in Korean Men.
Kim HJ; Park JH; Lee S; Son HY; Hwang J; Chae J; Yun JM; Kwon H; Kim JI; Cho B
PLoS One; 2015; 10(9):e0137564. PubMed ID: 26340433
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.
Borel AL; Nazare JA; Baillot A; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E273-E281. PubMed ID: 28028035
[TBL] [Abstract][Full Text] [Related]
7. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.
Boulet MM; Chevrier G; Grenier-Larouche T; Pelletier M; Nadeau M; Scarpa J; Prehn C; Marette A; Adamski J; Tchernof A
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E736-46. PubMed ID: 26306599
[TBL] [Abstract][Full Text] [Related]
8. Cardiac steatosis associates with visceral obesity in nondiabetic obese men.
Granér M; Siren R; Nyman K; Lundbom J; Hakkarainen A; Pentikäinen MO; Lauerma K; Lundbom N; Adiels M; Nieminen MS; Taskinen MR
J Clin Endocrinol Metab; 2013 Mar; 98(3):1189-97. PubMed ID: 23418318
[TBL] [Abstract][Full Text] [Related]
9. Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.
Rauzier C; Chartrand DJ; Alméras N; Lemieux I; Larose E; Mathieu P; Pibarot P; Lamarche B; Rhéaume C; Poirier P; Després JP; Picard F
Front Endocrinol (Lausanne); 2023; 14():1222101. PubMed ID: 37854178
[TBL] [Abstract][Full Text] [Related]
10. Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity.
DiNicolantonio JJ; Mehta V; Onkaramurthy N; O'Keefe JH
Prog Cardiovasc Dis; 2018; 61(1):3-9. PubMed ID: 29225114
[TBL] [Abstract][Full Text] [Related]
11. Relationships between circulating 25(OH) vitamin D, leptin levels and visceral adipose tissue volume: results from a 1-year lifestyle intervention program in men with visceral obesity.
Gangloff A; Bergeron J; Lemieux I; Tremblay A; Poirier P; Alméras N; Després JP
Int J Obes (Lond); 2020 Feb; 44(2):280-288. PubMed ID: 30926948
[TBL] [Abstract][Full Text] [Related]
12. The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial.
Christensen RH; Wedell-Neergaard AS; Lehrskov LL; Legård GE; Dorph EB; Nymand S; Ball MK; Zacho M; Christensen R; Ellingsgaard H; Rosenmeier JB; Krogh-Madsen R; Pedersen BK; Karstoft K
Trials; 2018 May; 19(1):266. PubMed ID: 29720225
[TBL] [Abstract][Full Text] [Related]
13. Association between exercise-induced change in body composition and change in cardiometabolic risk factors in postmenopausal South Asian women.
Lesser IA; Guenette JA; Hoogbruin A; Mackey DC; Singer J; Gasevic D; Lear SA
Appl Physiol Nutr Metab; 2016 Sep; 41(9):931-7. PubMed ID: 27507007
[TBL] [Abstract][Full Text] [Related]
14. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.
Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351
[TBL] [Abstract][Full Text] [Related]
15. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study.
Kouli GM; Panagiotakos DB; Kyrou I; Georgousopoulou EN; Chrysohoou C; Tsigos C; Tousoulis D; Pitsavos C
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):881-889. PubMed ID: 28851556
[TBL] [Abstract][Full Text] [Related]
17. Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy.
Campos RMDS; Masquio DCL; Corgosinho FC; Caranti DA; Ganen AP; Tock L; Oyama LM; Dâmaso AR
Diab Vasc Dis Res; 2019 Mar; 16(2):196-206. PubMed ID: 30688518
[TBL] [Abstract][Full Text] [Related]
18. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women.
Rossi AP; Fantin F; Zamboni GA; Mazzali G; Rinaldi CA; Del Giglio M; Di Francesco V; Barillari M; Pozzi Mucelli R; Zamboni M
Obesity (Silver Spring); 2011 Sep; 19(9):1747-54. PubMed ID: 21593811
[TBL] [Abstract][Full Text] [Related]
19. Adult weight change in relation to visceral fat and liver fat at middle age: The Netherlands epidemiology of obesity study.
Verkouter I; Noordam R; de Roos A; Lamb HJ; Rosendaal FR; van Heemst D; de Mutsert R
Int J Obes (Lond); 2019 Apr; 43(4):790-799. PubMed ID: 30026588
[TBL] [Abstract][Full Text] [Related]
20. Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.
Takei R; Inoue T; Sonoda N; Kohjima M; Okamoto M; Sakamoto R; Inoguchi T; Ogawa Y
PLoS One; 2019; 14(10):e0223302. PubMed ID: 31577826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
